Marex Group Plc Stock Today
| MRX Stock | 34.90 2.18 5.88% |
PerformanceInsignificant
| Odds Of DistressLow
|
Marex Group is trading at 34.90 as of the 5th of April 2025; that is 5.88 percent down since the beginning of the trading day. The stock's open price was 37.08. Marex Group has only a 8 % chance of going through financial distress over the next few years but had a somewhat insignificant performance during the last 90 days. The performance scores are derived for the period starting the 5th of January 2025 and ending today, the 5th of April 2025. Click here to learn more.
Business Domain Financial Services | IPO Date 25th of April 2024 | Classification Financials |
Medicis Pharmaceutical Corporationration, a specialty pharmaceutical company, engages in the development and marketing of various solutions for the treatment of dermatological and aesthetic conditions in the United States and Canada. The company has 70.82 M outstanding shares of which 156.53 K shares are now shorted by investors with about 0.58 days to cover. More on Marex Group plc
Moving together with Marex Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Marex Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President | Simon Born | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Investment Banking & Brokerage, Financial Services, NASDAQ Composite, NASDAQ Financial 100, Financials, Capital Markets, Pharmaceutical Products, Financial Services (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Marex Group can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Marex Group's financial leverage. It provides some insight into what part of Marex Group's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Marex Group plc (MRX) is traded on NASDAQ Exchange in USA. It is located in 155 Bishopsgate, London, United Kingdom, EC2M 3TQ and employs 2,425 people. Marex Group is listed under Investment Banking & Brokerage category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a total capitalization of 1.78 B. Marex Group plc runs under Capital Markets sector within Financials industry. The entity has 70.82 M outstanding shares of which 156.53 K shares are now shorted by investors with about 0.58 days to cover.
Marex Group plc has about 42.82 M in cash with 1.16 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.47.
Check Marex Group Probability Of Bankruptcy
Ownership AllocationMarex Group plc maintains a total of 70.82 Million outstanding shares. Marex Group plc secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 63.5 % of Marex Group plc outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Marex Ownership Details
Marex Group Historical Income Statement
Marex Stock Against Markets
Marex Group Corporate Management
| Mahesh Vittal | Chief Americas | Profile | |
| Harvey Moses | Head Development | Profile | |
| Ann Bull | Group Compliance | Profile | |
| Graham Francis | Group Officer | Profile | |
| Robert Coates | Head Relations | Profile | |
| Liz Barrett | Group HR | Profile | |
| Michael Dugan | Chief Officer | Profile |
Additional Tools for Marex Stock Analysis
When running Marex Group's price analysis, check to measure Marex Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marex Group is operating at the current time. Most of Marex Group's value examination focuses on studying past and present price action to predict the probability of Marex Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marex Group's price. Additionally, you may evaluate how the addition of Marex Group to your portfolios can decrease your overall portfolio volatility.